Herpes Simplex Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
The human cytomegalovirus (CMV) a sequence has significant homology to two regions, pac-1 and pac-2, within the a sequence of herpes simplex virus type 1 (HSV-1).
|
2552148 |
1989 |
Adenocarcinoma of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
These data functionally define a novel genetic locus, designated PAC1, for prostate adenocarcinoma 1, involved in tumor suppression of human prostate carcinoma and furthermore strongly suggest that the cell death pathway can be functionally restored in prostatic adenocarcinoma.
|
8637912 |
1996 |
Retinoblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Three full-length cDNAs encoding functional splice variants of the pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1) were isolated from Y-79 retinoblastoma cells and human cerebellum.
|
10583729 |
1999 |
Acute leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our results suggest that ERK is constitutively activated in a majority of acute leukemias, and in addition to the activation of MEK, the hyperexpression of ERK and downregulation of PAC1 also contribute to constitutive ERK activation in acute leukemias.
|
10339498 |
1999 |
Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
The expression analysis of the DSCR2 gene in different human tumour derived cell lines indicates that the gene is expressed in all proliferating cell lines tested.
|
10872820 |
2000 |
Glioma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Relative to normal human brain, PAC1-R expression is significantly upregulated in glioma, particularly oligodendrogliomas.
|
10867818 |
2000 |
Brain Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
To determine the role of PACAP and PAC1-R expression on glial proliferation, two in vivo models were examined--human brain tumors of glial origin and the reactive gliosis induced by a penetrating stab wound to the mature rat brain.
|
10867818 |
2000 |
Malignant neoplasm of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Although mRNA for VPAC2-R is not common, VPAC1-R and PAC1-R mRNA is present in many lung cancer cell lines.
|
11193832 |
2000 |
Carcinoma of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Although mRNA for VPAC2-R is not common, VPAC1-R and PAC1-R mRNA is present in many lung cancer cell lines.
|
11193832 |
2000 |
Primary malignant neoplasm of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Although mRNA for VPAC2-R is not common, VPAC1-R and PAC1-R mRNA is present in many lung cancer cell lines.
|
11193832 |
2000 |
oligodendroglioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Relative to normal human brain, PAC1-R expression is significantly upregulated in glioma, particularly oligodendrogliomas.
|
10867818 |
2000 |
Well Differentiated Oligodendroglioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Relative to normal human brain, PAC1-R expression is significantly upregulated in glioma, particularly oligodendrogliomas.
|
10867818 |
2000 |
Retinoblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
These experiments demonstrate that GRK3 plays an important role in the homologous desensitization of retinoblastoma PAC(1) receptors, whereas PKC, but not PKA, contributes to the heterologous desensitization of retinoblastoma PAC(1) receptors.
|
11166332 |
2001 |
Malignant neoplasm of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
These results suggest that PAC(1) and VPAC(1) receptors regulate VEGF expression in lung cancer cells.
|
12409225 |
2002 |
Carcinoma of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
These results suggest that PAC(1) and VPAC(1) receptors regulate VEGF expression in lung cancer cells.
|
12409225 |
2002 |
Primary malignant neoplasm of lung
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
These results suggest that PAC(1) and VPAC(1) receptors regulate VEGF expression in lung cancer cells.
|
12409225 |
2002 |
Leukemia, Large Granular Lymphocytic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
By screening a LGL leukemia cDNA library using the 3' end of a PAC-1 probe, we obtained a clone (clone 8) which retains one and one half introns, excludes two exons, and matches one hundred percent with a DNA sequence on chromosome 2.
|
14680939 |
2003 |
Malignant transformation
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
In conclusion, we demonstrate the expression of functional PAC(1), VPAC(1) and VPAC(2) receptors in human prostate as well as its maintenance after malignant transformation.
|
12948842 |
2003 |
Malignant neoplasm of breast
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PAC1 has been shown previously to be expressed and regulate the growth and proliferation of nonsquamous cell lung cancer cells, as well as breast cancer cell lines.
|
14742913 |
2004 |
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the current study, we contrast the effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on the HCT8 colon cancer cell lines to the HCT116 and FET cell lines wherein PAC1 is expressed as the SV1 or HIP splice variant and is coupled to the activation only of cAMP but not of intracellular Ca2+.
|
14742913 |
2004 |
Colonic Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
These data indicate that human colon tumor cells express PAC1 and are differentially coupled to intracellular signal transduction molecules.
|
14742913 |
2004 |
Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PAC1 has been shown previously to be expressed and regulate the growth and proliferation of nonsquamous cell lung cancer cells, as well as breast cancer cell lines.
|
14742913 |
2004 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the current study, we contrast the effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on the HCT8 colon cancer cell lines to the HCT116 and FET cell lines wherein PAC1 is expressed as the SV1 or HIP splice variant and is coupled to the activation only of cAMP but not of intracellular Ca2+.
|
14742913 |
2004 |
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
A weaker immunostaining of PAC1 receptors in normal tissue and a strong density of the three PACAP/VIP receptor subclasses in cancer tissue may be related to differential expression patterns during breast tumor progression but more samples need to be studied to validate this hypothesis.
|
16019382 |
2005 |
Primary malignant neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
A weaker immunostaining of PAC1 receptors in normal tissue and a strong density of the three PACAP/VIP receptor subclasses in cancer tissue may be related to differential expression patterns during breast tumor progression but more samples need to be studied to validate this hypothesis.
|
16019382 |
2005 |